Elena Edelman

Affiliations: 
Duke University, Durham, NC 
Area:
Computational Biology
Google:
"Elena Edelman"
Mean distance: 16.01 (cluster 29)
 
SNBCP
Cross-listing: Computational Biology Tree

Parents

Sign in to add mentor
Sayan Mukherjee grad student 2008 Duke
 (Modeling cancer progression on the pathway level.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Stransky N, Ghandi M, Kryukov GV, et al. (2015) Pharmacogenomic agreement between two cancer cell line data sets Nature. 528: 84-87
Faber AC, Farago AF, Costa C, et al. (2015) Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 112: E1288-96
Edelman EJ, Tate JP, Fiellin DA, et al. (2015) Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system. Hiv Medicine. 16: 346-54
Marshall BD, Operario D, Bryant KJ, et al. (2015) Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans. Drug and Alcohol Dependence. 148: 69-76
Faber AC, Coffee EM, Costa C, et al. (2014) mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1. Cancer Discovery. 4: 42-52
Chen EY, Dobrinski KP, Brown KH, et al. (2013) Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma. Plos Genetics. 9: e1003727
Yang W, Soares J, Greninger P, et al. (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Research. 41: D955-61
Garnett MJ, Edelman EJ, Heidorn SJ, et al. (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature. 483: 570-5
Garman KS, Acharya CR, Edelman E, et al. (2011) Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. Proceedings of the National Academy of Sciences of the United States of America. 108: 17569
Takahashi F, Chiba N, Tajima K, et al. (2011) Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. Oncogene. 30: 3084-95
See more...